Inhibitory effect of morin on DMH-induced biochemical changes and aberrant crypt foci formation in experimental colon carcinogenesis

Environmental Toxicology and Pharmacology

Volumn 29, Issue 1, 2010, Pages 50-57

  Karthik Kumar, Venkatachalam ^a   Vennila, Sreedharan ^a   Nalini, Namasivayam ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

ACF; Colon cancer; DMH; Glycoconjugates; Lipids

Indexed keywords

1,2 DIMETHYLHYDRAZINE; CHOLESTEROL; FATTY ACID; FUCOSE; GLYCOCONJUGATE; HEXOSAMINE; HEXOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MORIN; PHOSPHOLIPID; SIALIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCENDING COLON; CANCER PREVENTION; CECUM; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; CRYPT CELL; DESCENDING COLON; DIET SUPPLEMENTATION; DRUG SAFETY; ENZYME ACTIVITY; ENZYME INHIBITION; HISTOPATHOLOGY; LIVER; MALE; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE LEVEL;

RATTUS;

EID: 72149084387     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2009.09.006     Document Type: Article

References (49)

1. Aminoff D. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem. J. 81 (1961) 384-392
2. Aranganathan S., Senthil K., and Nalini N. A case control study of glycoprotein status in ovarian carcinoma. Clin. Biochem. 38 (2005) 535-539
3. Beckmann J.S., Argov Z., and Mitrani R.S. The UDO-N-acetylglucosamine 2 epimerase/N acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat. Genet. 29 (2001) 83-87
4. Bird R.P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 37 (1987) 147-151
5. Bird R.P., and Good C.K. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol. Lett. 112-113 (2000) 395-402
6. Boateng J., Verghese M., Chawan C.B., Shackelford L., Khatiwada J., and Williams D.S. Red palm oil suppresses the formation of azoxymethane (AOM) induced aberrant crypt foci (ACF) in Fisher 344 male rats. Food Chem. Toxicol. 44 (2006) 1667-1673
7. Boone C.W., Kelloff C.J., and Malone W.E. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review. Cancer Res. 50 (1990) 2-9
8. Brasitus T.A., Dudeja P.K., and Dahiya R. Premalignant alterations in the lipid composition and fluidity of colonic brush border membranes of rats administered 1,2-dimethylhydrazine. J. Clin. Invest. 77 (1986) 831-840
9. Brown J., O'Prey J., and Harrison P.R. Enhanced sensitivity of human oral tumours to the flavonol, morin, during cancer progression: involvement of the Akt and stress kinase pathways. Carcinogenesis 24 (2003) 171-177
10. Carrol K.K., Braden L.M., Bell J.A., and Kalamegham R. Fat and cancer. Cancer 58 (1986) 1818-1825
11. Cooper H.K., Buecheler J., and Kleihues P. DNA alkylation in mice with genetically different susceptibility to 1,2-dimethylhydrazine-induced colon carcinogenesis. Cancer Res. 38 (1978) 3063-3065
12. Cooper L.A., Lesile M.H., Kright D., and Detwater D.K. Red cell environment and spur cell anaemia in dogs fed a cholesterol enriched artherogenic diet. J. Lipid Res. 21 (1989) 1082-1085
13. Dennis J.W., Granovsky M., and Warren C.E. Glycoprotein glycosylation and cancer progression. Biochim. Biophys. Acta 1473 (1999) 21-34
14. Dennis J.W., Kosh K., Brycc D.M., and Breitman M.L. Oncogenes conferring metastatic potential induce increased branching of asn-linked oligosaccharides in rat 2 fibroblasts. Oncogene 4 (1989) 853-860
15. Dische L., and Shettles L.B. A specific color reaction of methyl pentoses and a spectrophotometric micromethod for their determination. J. Biol. Chem. 175 (1948) 595-603
16. Falholt K., Lund B., and Falholt W. An easy micromethod for routine determination of free fatty acids in plasma. Clin. Chim. Acta 46 (1973) 105-111
17. Folch J., Lees M., and Sloane Stanely G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1957) 497-509
18. Freeman H.J., Kim Y., and Kim Y.S. Glycoprotein metabolism in normal proximal and distal at colon and changes associated with 1,2-dimethylhydrazine-induced colonic neoplasia. Cancer Res. 38 (1978) 3385-3390
19. Garder R.A., and Brennes R.R. In-vitro modifications of cholesterol content of rat liver microsomes. Effect upon membrane fluidity and activities of glucose-6-phosphatase and folic acid disruption system. Biochim. Biophys. Acta 819 (1985) 45-51
20. Gold P., Gold M., and Freedman S.O. Cellular location of carcinoembryonic antigens of the human digestive system. Cancer Res. 28 (1968) 1331-1334
21. Herlyn M., and Malkowicz S.B. Regulatory pathways in tumor growth and invasion. Lab. Investig. 65 (1991) 262-271
22. James J.T., and Autrup H. Methylated DNA adducts in the large intestine of ICR/Ha and C57BL/Ha mice given 1,2-dimethylhydrazine. J. Natl. Cancer Inst. 70 3 (1983) 541-546
23. Johnson J.J., and Mukhtar H. Curcumin for chemoprevention of colon cancer. Cancer Lett. 255 (2007) 170-181
24. Kamaleeswari M., Deeptha K., Sengottuvelan M., and Nalini N. Effect of dietary caraway (Carum carvi L.) on aberrant crypt foci development, fecal steroids, and intestinal alkaline phosphatase activities in 1,2-dimethylhydrazine-induced colon carcinogenesis. Toxicol. Appl. Pharm. 214 (2006) 290-296
25. Kim Y.S., Isaacs R., and Perdomo J.M. Alterations of membrane glycopeptides in human colonic adenocarcinoma. Proc. Natl. Acad. Sci. U.S.A. 71 (1974) 4869-4873
26. Longo W.E., Grossman E.M., Erickson B., Panosar N., Mazuski J.E., and Kaminski D.L. The effect of phospholipase A2 inhibitors on proliferation and apoptosis of marine intestinal cells. J. Surg. Res. 84 (1999) 51-56
27. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with Folins phenol reagent. J. Biol. Chem. 93 (1951) 265-275
28. Middleton E., Kandaswami C., and Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 52 (2000) 673-751
29. Nalini N., Sabitha K., Chitra S., Viswanathan P., and Menon V.P. Histopathological and lipid changes in experimental colon cancer: effect of coconut kernal (Cocos nucifera Linn.) and (Capsicum annum Linn.) red chilly powder. Indian J. Exp. Biol. 35 (1997) 964-971
30. National Research Council. Diet, Nutrition and Cancer (1982), National Academy Press, Washington
31. Niebes P. Determination of enzymes and degradation products of glycosaminoglycan metabolism in the serum of healthy and varicose subjects. Clin. Chim. Acta 42 (1972) 399-408
32. Philipson B.E., Rothrock D.W., Connor W.E., Harris W.S., and Illingworth D.R. Reduction of plasma lipids, lipoproteins and apoproteins by dietary fish oils in patients with hypertriglyceridemia. New Engl. J. Med. 312 (1985) 1210-1219
33. Pretlow T.P., O'Riordan M.A., Pretlow T.G., and Stellato T.A. Aberrant crypts in human colonic mucosa: putative preneoplastic lesions. J. Cell. Biochem. 16G Suppl. (1992) 55-62
34. Rao V., and Ramakrishnan S. Indirect assessment of hydroxy methyl glutaryl CoA reductase activity in liver tissue. J. Clin. Chem. 21 (1975) 1523-1527
35. Reddy B.S., Weisburger J.H., and Wynder E.L. Effects of dietary fat level and dimethylhydrazine on fecalacid and neutral sterol excretion and colon carcinogenesis in rats. J. Natl. Cancer. I 52 (1974) 507-511
36. Rodrigues M.A.M., Silva L.A.G., Salvadori D.M.F., De Camargo J.L.V., and Mantenegro M.R. Aberrant crypt foci and colon cancer: comparison between a short- and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats. Braz. J. Med. Biol. Res. 35 (2002) 351-355
37. Sengottuvelan M., Senthilkumar R., and Nalini N. Modulatory influence of dietary resveratrol during different phases of 1,2-dimehtylhydrazine induced mucosal lipid-peroxidation, antioxidant status and aberrant crypt foci development in rat colon carcinogenesis. Biochim. Biophys. Acta 1760 (2006) 1175-1183
38. Shelton B.K. Introduction to colorectal cancer. Semin. Oncol. Nurs. 18 (2002) 2-12
39. Siu W.Y., Arooz T., and Poon R.Y. Differential responses of proliferating versus quiescent cells to adriamycin. Exp. Cell. Res. 250 (1999) 131-141
40. Smith C., Halliwell B., and Aruoma O.I. Protection by albumin against the pro-oxidant actions of phenolic dietary components. Food Chem. Toxicol. 30 (1992) 483-489
41. Takahashi M., Minamoto T., Yamashita N., Yazawa K., Sugimura T., and Esumi H. Reduction in formation and growth of 1,2-dimethylhydrazine-induced aberrant crypt foci in rat colon by docosahexaenoic acid. Cancer Res. 53 (1993) 2786-2789
42. Tanaka T., Kawabata K., Kakumoto M., Makita H., Ushida J., Honjo S., Hara A., and Tsuda H. Modifying effects of a flavonoid morin on azoxymethane induced large bowel tumorigenesis in rats. Carcinogenesis 20 (1999) 1477-1484
43. Thompson S., Cantwell B.M.J., Cornell I., and Turner G.A. Abnormally fucosylated haptoglob a cancer marker for tumour burden but not gross liver metastasis. Br. J. Cancer 64 (1991) 386-390
44. Wagner W.D. More sensitive assay discriminating galactosamine and glucosamine in mixtures. Anal. Biochem. 94 (1972) 394-397
45. Wargovich M.J., Jimenez A., McKee K., Steele V.E., Velasco M., Woods J., Price R., Gray K., and Kelloff G.J. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis 21 (2000) 1149-1155
46. Watten L.W. Chemoprevention of cancer by naturally occurring and synthetic compounds. In: Wattenberg L.W., Lipkin M., Boone C.W., and Kelloff G.J. (Eds). Cancer Chemoprevention (1992), CRC Press, Boca Raton, FL 19-39
47. Weisburger J.H. Colon carcinogens: their metabolism and mode of action. Cancer 28 (1971) 60-71
48. Zilversmit D.B., and Davis A.K. Microdetermination of plasma phospholipids by trichloroacetic acid precipitation. J. Lab. Clin. Med. 35 (1950) 155-160
49. Zletkis A., Zak B., and Boyle A.J. A new method for the direct determination of serum cholesterol. J. Lab. Clin. Med. 41 (1953) 486-492